The abstract is read at the publisher; the summary is JClub's.
Transduction of AAV2 and AAV9 in AML12 and HuH-7 cells is controlled by both shared and many serotype- and species-specific host factors, with species effects stronger for the same serotype.
- Why it matters: AAV gene delivery depends on host-cell interactions that are not fully mapped, limiting the ability to predict or tailor biodistribution across serotypes and species.
- What they did: CRISPR-Cas9 whole-genome knockdown screens were run in mouse (AML12) and human (HuH-7) cells, followed by AAV2 or AAV9 transduction, confirming AAVR and GPR108 and revealing additional modulators.
- The result: Transient GalNac-siRNA downregulation of key entry factors before AAV9 administration blunted liver transduction and redirected the vector to other permissive tissues.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.